Plain-English translation of NCT06050707 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a new way to deliver radiation therapy for anal cancer using advanced MRI-guided technology. Instead of giving all patients the same dose, this study tailors your treatment — including radiation and chemotherapy — based on your individual tumor characteristics and risk factors. The goal is to improve outcomes while managing side effects more carefully.
Anal cancer treatment is challenging because doctors need to balance curing the cancer with protecting nearby healthy tissue and organs. This new treatment approach uses advanced imaging to personalize each patient's care, which could lead to better results for some patients without increasing harm.
You likely qualify if…
You likely don't qualify if…
You will receive radiation therapy delivered using an MRI-guided machine, which allows doctors to see the tumor in real-time and adjust your treatment for precision. Your radiation plan and chemotherapy cycles will be customized based on your specific risk factors. After treatment ends, you will have follow-up clinic visits and complete questionnaires for up to 5 years to monitor your recovery. You may also be asked to provide optional blood and tissue samples to help researchers understand what works best.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
United States
Australia
Canada